Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

Hagai Tavori; Michelle Melone; Shirya Rashid

doi:10.1586/14779072.2014.986028

Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

Hagai Tavori, Michelle Melone, Shirya Rashid

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1491
Number of pages	1
Journal	Expert Review of Cardiovascular Therapy
Volume	12
Issue number	12
DOIs	https://doi.org/10.1586/14779072.2014.986028
State	Published - Dec 1 2014
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1586/14779072.2014.986028

Cite this

@article{2fa421fdbd1e4a93bcd3040fcf23e9a5,

title = "Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction",

author = "Hagai Tavori and Michelle Melone and Shirya Rashid",

year = "2014",

month = dec,

day = "1",

doi = "10.1586/14779072.2014.986028",

language = "English (US)",

volume = "12",

pages = "1491",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",

publisher = "Expert Reviews Ltd.",

number = "12",

}

TY - JOUR

T1 - Correction to

T2 - Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

AU - Tavori, Hagai

AU - Melone, Michelle

AU - Rashid, Shirya

PY - 2014/12/1

Y1 - 2014/12/1

UR - http://www.scopus.com/inward/record.url?scp=84912060549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912060549&partnerID=8YFLogxK

U2 - 10.1586/14779072.2014.986028

DO - 10.1586/14779072.2014.986028

M3 - Comment/debate

AN - SCOPUS:84912060549

SN - 1477-9072

VL - 12

SP - 1491

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

IS - 12

ER -

Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this